Dec 19, 2018

Pfizer, GlaxoSmithKline to merge over-the-counter drugs

Pfizer's over-the-counter products include Advil. Photo: Roberto Machado Noa/LightRocket via Getty Images

Pfizer and GlaxoSmithKline intend to combine their respective businesses that sell over-the-counter products and then spin out the merged company into its own publicly traded entity, the companies said Wednesday. GSK would own 68% of the company, and Pfizer would own the other 32%.

Why it matters: GSK previously pulled out of buying Pfizer's consumer business. This deal would heavily consolidate common health products — ranging from Pfizer's Advil and Nexium to GSK's Aquafresh toothpaste, Excedrin and Tums — into one $13 billion drug giant.

Go deeper

America's funeral homes buckle under the coronavirus

Illustration: Aïda Amer/Axios

Morgues, funeral homes and cemeteries in hot spots across America cannot keep up with the staggering death toll of the coronavirus pandemic.

Why it matters: The U.S. has seen more than 10,000 deaths from the virus, and at least tens of thousands more lives are projected to be lost. The numbers are creating unprecedented bottlenecks in the funeral industry — and social distancing is changing the way the families say goodbye to their loved ones.

Go deeperArrow33 mins ago - Health

Navarro memos warning of mass coronavirus death circulated in January

Image from a memo to President Trump

In late January, President Trump's economic adviser Peter Navarro warned his White House colleagues the novel coronavirus could take more than half a million American lives and cost close to $6 trillion, according to memos obtained by Axios.

The state of play: By late February, Navarro was even more alarmed, and he warned his colleagues, in another memo, that up to two million Americans could die of the virus.

Go deeperArrowUpdated 1 hour ago - Health

Axios-Ipsos Coronavirus Index: The virus hits home

Data: Ipsos/Axios poll; Chart: Danielle Alberti/Axios

The share of Americans who know someone who's tested positive has more than tripled in just a few weeks, to 14%, according to the latest installment of our Axios-Ipsos Coronavirus Index.

  • It's still highest in the Northeast, but last week alone it doubled in the South — and it's becoming most pronounced among people who still must leave home to work.